BIO-RAD LABORATORIES, INC. — Director's Dealing 2012

Dec 7, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIO RAD LABORATORIES INC (BIO, BIO.B)
CIK: 0000012208
Period of Report: 2012-12-06

Reporting Person: Magni Giovanni (Vice President, Intl Sales)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2012-12-06	Bio-Rad A Common Stock	M	5605	$35.50	Acquired	13593	Direct
2012-12-06	Bio-Rad A Common Stock	S	5404	$103.85	Disposed	8189	Direct
2012-12-06	Bio-Rad A Common Stock	S	201	$104.76	Disposed	7988	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2012-12-06	Incentive Stock Option (right to buy)	$35.50	M	4885	Disposed	2013-02-05	Bio-Rad A Common Stock (4885)	Direct
2012-12-06	Non-Qualified Stock Option (right to buy)	$35.50	M	720	Disposed	2013-02-05	Bio-Rad A Common Stock (720)	Direct

Footnotes

F1: The option vested in five equal annual installments beginning on February 5, 2004.

F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $103.60 to $104.59, inclusive. The reporting person undertakes to provide to Bio-Rad Laboratories, Inc., any security holder of Bio-Rad Laboratories, Inc., or the staff of the Securites and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $104.62 to $104.81, inclusive. The reporting person undertakes to provide to Bio-Rad Laboratories, Inc., any security holder of Bio-Rad Laboratories, Inc., or the staff of the Securites and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.